Departments

Medical Departments

Radionucleide Therapy (Nuclear Department)

Utilisation thérapeutique des radio-isotopes en Belgique dans la période 1990-2005

 

References :

1) Ferrant A, Cogneau M, Leners N, Jamr F, Martiat P, Michaux JL «52Fe for additional marrow ablation befor e bone marrow transplantation” Blood 1993:81:3435-3439

 

2) Glinoer D “Radioidoine therapy of non toxic multinodular goitre” Clin Endocrinol (Oxf) 1994:41:713-714

 

3) Daumerie C, Vynckier S, Caussin J, Jadoul M, Squifflet JP, de Patoul M, Wanbersie A

“Radioiodine treatment of thyroid carcinoma in patients on maintenance hemodialysis”

Thyroid 1996:6:301-304

 

4) Nguyen H, Ghanem G, Morandini R, Verbist A, Larsimont D, Fallais C, Fruhling J, Van Houtte P „Tumor type and vascularity: important variables in infusional brachytherapy with colloidal 32P” Int J Radiat Oncol Biol Phys 1997:39:481-487

 

5) Hennen G, McNamara EM, Docker A, Joachim M “Radioiodine 131I as the only treatment of hyperthyroidiem. Results of 10 years of experience” Rev Med Liège 1999:54:611-617

 

6) Beckers C « 1361I therapy of toxic and non toxic goiters » Q J Nucl Med 1999:43:291-296

 

7) Mangold CA, Rijnders A, Georg D, Van Limbergen E, Potter R, Husykens D «Quality control in interstitial brachytherapy of the breast using pulsed dose rate ; treatment planning and dose delivery with an Ir-192 afterloading system » Radiother Oncol 2001 :5 :43-51

 

8) Reynaert N, Vna Eijkeren M, Taeymans Y, Thierens H “Dosimetry of 192Ir sources used for endovascular brachytherapy” Phys Med Biol 2001:46:499-516

 

9) Monsieurs M, Brans M, Bacher K, Dierckx R, Thierens H “Patients dosimetry for 131I-MIBG therapy for neuroendocrine tumors based on 123I-MIBG scans” Eur J Nucl Med Mel Imaging 2002:29:1581-1587

 

10) De Ruyck K, Lambert B, Bac her K, Gemmel F, De Vos F, Vral A, de Ridder I, Dierckx RA, Thierens H “Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-Lipiodol therapy in patients with hepatocellular carcinoma” J Nucl Med 2004:45:612-618

 

11) Lambert B, Van de Wiele C “Treatment of hepatocellular carcinomas by means of radiopharmaceuticals” Eur J Nucl Med Mol Imaging 2005:32:980-989

 

12) Lambert B, Praet M, Vanlangenhove P, Trosi R, de Hemptinne B, Gemmel F, Van Vlierberghe H, Van de Wiele C “Radiolabelled lipiodol therapy for hepatocellular carcinoma in patients awaiting liver transplantation: pathology of the explants liver and clinical outcome” Cancer Biother Radiopharm 2005:20:209-214

 

13) Nickers P, Thissen B, Jansen N, Deneufbourg JM “192Ir or 125I prostate brachytherapy as a boost to external beam radiotherapy in locally advanced prostatic cancer: a dosimetric point of view” Radiother Oncol 2006:78:47-52

 

 

Person in charge : Pr Patrick Flamen